Homrich & Berg’s Labcorp LH Stock Holding History

Homrich & Berg’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,191	Closed	-$327K	–	319
2018 Q3	$327K	Buy	2,191 +603	+38%	+$91.7K	0.02%	258
2018 Q2	$245K	Buy	+1,588	New	+$240K	0.02%	283

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Homrich & Berg's LH Position: Q4 2018 in Review

Homrich & Berg sold out of Labcorp (LH) in Q4 2018, closing a stake of 2,191 shares — an estimated $327K sold.

Homrich & Berg first reported a position in LH in Q2 2018 and held it in 2 quarters. The position peaked at $327K in Q3 2018. 742 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Homrich & Berg reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Homrich & Berg sold 2,191 Labcorp shares in Q4 2018, an estimated $327K.
Homrich & Berg first reported a position in Labcorp in Q2 2018 and held it in 2 quarters.
Homrich & Berg's Labcorp position peaked at $327K in Q3 2018.
742 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Homrich & Berg's 13F filing for Q4 2018, filed 6 Feb 2019.